Explore the pivotal role of ALDH1A3 in breast cancer progression highlighted in a recent study, reinforcing Theranib’s mission to advance ALDH1A3-targeted therapies.
Theranib at OBIO Investment Summit 2026
Thrilled to share that Theranib has been invited to pitch at OBIO in Toronto (Feb 3–6) 🇨🇦It’s an exciting opportunity to present our vision and progress to a community that’s shaping the future of biotech innovation.If you’re attending and interested in…